XML 36 R20.htm IDEA: XBRL DOCUMENT
v3.20.4

Stock Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2020
Stock Based Compensation [Abstract] |
Stock Based Compensation | NOTE 12 - STOCK BASED COMPENSATION At the Annual Meeting held on April 22, 2014, the Company’s stockholders approved the Norwood Financial Corp 2014 Equity Incentive Plan. An aggregate of 375,000 shares of authorized but unissued Common Stock of the Company were reserved for future issuance under the Plan. This includes up to 60,000 shares for awards to outside directors. The Plan also authorized the Company to award restricted stock to officers and outside directors, limited to 63,000 shares of restricted stock awards for officers and 12,000 shares of restricted stock awards for outside directors. At the Annual Meeting held on April 24, 2018, the Company’s stockholders approved an amendment to the 2014 Equity Incentive Plan to ease certain restrictions on restricted stock awards to outside directors. As a result of this amendment, the number of shares available for restricted stock awards to officers was reduced by 300 shares to 62,700, while the number of shares available for restricted stock awards to outside directors was increased by 20,300 to 32,300 shares. Under this plan, the Company granted 245,465 shares which included 148,365 options to employees, 10,400 options to directors, 56,625 shares of restricted stock to officers and 30,075 shares of restricted stock to directors. The restricted shares vest over five years. The product of the number of shares granted and the grant date market price of the Company’s common stock determine the fair value of restricted stock under the company’s restricted stock plan. Management recognizes compensation expense for the fair value of restricted stock on a straight-line basis over the requisite service period for the entire award. As of December 31, 2020, there were 129,535 shares available for future awards under this plan, which includes 110,010 shares available for officer awards and 19,525 shares available for awards to outside directors. Included in these totals are 6,075 shares available for restricted stock awards to officers and 2,225 shares available for restricted stock awards to outside directors. All share information has been restated to reflect the 50% stock dividend declared in 2017. Total unrecognized compensation cost related to stock options was $214,000 as of December 31, 2020 and $203,000 as of December 31, 2019. Salaries and employee benefits expense includes $204,000 and $208,000 of compensation costs related to options for the years ended December 31, 2020 and 2019, respectively. Compensation costs related to restricted stock amounted to $334,000 and $289,000 for the years ended December 31, 2020 and 2019, respectively. The expected future compensation expense relating to non-vested restricted stock outstanding as of December 31, 2020 and 2019 was $1,202,000 and $1,146,000, respectively. A summary of the Company’s stock option activity and related information for the years ended December 31 follows:
| 2020 |  | 2019
|  |  | Weighted |  |  |  |  |  | Weighted |  |
|  |  | Average |  | Average |  |  |  | Average |  | Average
|  |  | Exercise |  | Intrinsic |  |  |  | Exercise |  | Intrinsic
| Options |  | Price |  | Value |  | Options |  | Price |  | Value
Outstanding, beginning of year | 199,825 |  | $ | 24.78 |  |  |  |  | 208,700 |  | $ | 22.54 |  |  |
Granted | 33,750 |  |  | 26.93 |  |  |  |  | 26,750 |  |  | 36.02 |  |  |
Exercised | (15,530) |  |  | 17.25 |  |  |  |  | (32,350) |  |  | 19.71 |  |  |
Forfeited | (2,075) |  |  | 16.83 |  |  |  |  | (3,275) |  |  | 24.31 |  |  |
Outstanding, end of year | 215,970 |  | $ | 25.73 |  | $ | 742,738 |  | 199,825 |  | $ | 24.78 |  | $ | 2,822,470
Exercisable, end of year | 182,220 |  | $ | 25.51 |  | $ | 742,738 |  | 173,075 |  | $ | 23.04 |  | $ | 2,745,430
Exercise prices for options outstanding as of December 31, 2020 ranged from $16.65 to $36.02 per share. The weighted average remaining contractual life is 6.0 years. The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:
| Years Ended December 31,
| 2020 |  | 2019
Dividend yield |  | 3.55% |  |  | 3.59%
Expected life |  | 10 years |  |  | 10 years
Expected volatility |  | 34.15% |  |  | 29.08%
Risk-free interest rate |  | 0.91% |  |  | 1.92%
Weighted average fair value of options granted | $ | 6.34 |  | $ | 7.61
The expected volatility is based on historical volatility. The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life is based on historical exercise experience. The dividend yield assumption is based on the Company’s history and expectation of dividend payouts. Proceeds from stock option exercises totaled $268,000 in 2020. Shares issued in connection with stock option exercises are issued from available treasury shares or from available authorized shares. During 2020, for the shares issued in connection with stock option exercises, 15,530 shares in total, all shares were issued from available authorized shares. As of December 31, 2020, outstanding stock options consist of the following:
|  |  | Average |  |  |  |  |  | Average
| Options |  | Exercise |  | Remaining |  | Options |  | Exercise
| Outstanding |  | Price |  | Life, Years |  | Exercisable |  | Price
| 18,000 |  | $ | 16.65 |  | 1.0 |  | 18,000 |  | $ | 16.65
| 23,100 |  |  | 18.03 |  | 2.0 |  | 23,100 |  |  | 18.03
| 1,650 |  |  | 18.36 |  | 2.0 |  | 1,650 |  |  | 18.36
| 3,000 |  |  | 19.30 |  | 2.8 |  | 3,000 |  |  | 19.30
| 20,125 |  |  | 17.93 |  | 3.0 |  | 20,125 |  |  | 17.93
| 8,250 |  |  | 19.39 |  | 3.9 |  | 8,250 |  |  | 19.39
| 9,375 |  |  | 19.03 |  | 4.9 |  | 9,375 |  |  | 19.03
| 16,120 |  |  | 22.37 |  | 6.0 |  | 16,120 |  |  | 22.37
| 29,500 |  |  | 32.81 |  | 7.0 |  | 29,500 |  |  | 32.81
| 26,350 |  |  | 32.34 |  | 8.0 |  | 26,350 |  |  | 32.34
| 26,750 |  |  | 36.02 |  | 9.0 |  | 26,750 |  |  | 36.02
| 33,750 |  |  | 26.93 |  | 10.0 |  | — |  |  | —
Total | 215,970 |  |  |  |  |  |  | 182,220 |  |  |
A summary of the Company’s restricted stock activity and related information for the years ended December 31 is as follows:
|  | 2020 |  | 2019
|  |  |  | Weighted-Average |  |  |  | Weighted-Average
|  | Number of |  | Grant Date |  | Number of |  | Grant Date
|  | Shares |  | Fair Value |  | Shares |  | Fair Value
Non-vested, beginning of year |  | 36,195 |  | 31.65 |  | 34,615 |  | 27.82
Granted |  | 14,500 |  | 26.93 |  | 13,100 |  | 36.02
Vested |  | (11,560) |  | 32.89 |  | (11,520) |  | 25.12
Forfeited |  | — |  | — |  | — |  | —
Non-vested at December 31 |  | 39,135 |  | 30.72 |  | 36,195 |  | 31.65

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration